The DOI matches its Crossref record; 89 of the 91 references it cites were found in a registry or an index.
Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation
Open accessAbstract
Summary: This paper considers the argument for obesity as a chronic relapsing disease process. Obesity is viewed from an epidemiological model, with an agent affecting the host and producing disease. Food is the primary agent, particularly foods that are high in energy density such as fat, or in sugar‐sweetened beverages. An abundance of food, low physical activity and several other environmental factors interact with the genetic susceptibility of the host to produce positive energy balance. The majority of this excess energy is stored as fat in enlarged, and often more numerous fat cells, but some lipid may infiltrate other organs such as the liver (ectopic fat). The enlarged fat cells and ectopic fat produce and secrete a variety of metabolic, hormonal and inflammatory products that produce damage in organs such as the arteries, heart, liver, muscle and pancreas. The magnitude of the obesity and its adverse effects in individuals may relate to the virulence or toxicity of the environment and its interaction with the host. Thus, obesity fits the epidemiological model of a disease process except that the toxic or pathological agent is food rather than a microbe. Reversing obesity will prevent most of its detrimental effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The causes of obesity are multifactorial and incompletely understood.2,5,80”
From Definition and diagnostic criteria of clinical obesity (2025) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As reviewed in a statement from the World Obesity Federation95, many medical societies as well as the World Health Organization, the US Food and Drug Association, the US National Institutes of Health, and the Nagoya Declaration have now defined obesity as a disease or disease process.”
From Joint international consensus statement for ending stigma of obesity (2020) · cites this paper as [95]
Experimental — accuracy not yet measuredIn the citing paper
“the obesogenic environment that continues to fuel this pandemic on a population level in the USA and other nations [121]”
From The Role of Lifestyle Modification with Second-Generation Anti-obesity Medications: Comparisons, Questions, and Clinical Opportunities (2023) · cites this paper as [121]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
Prospective Studies Collaboration (2009) · The Lancet · doi:10.1016/s0140-6736(09)60318-4 · Cited by 4,807
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668
Genetic studies of body mass index yield new insights for obesity biology
Study, T. L. C., Locke, A. E., The ADIPOGen Consortium, The AGEN-BMI Working Group, The CARDIOGRAMplusC4D Consortium, The CKDGen Consortium, The, G. L. G. C., The, I. C. B. P., The MAGIC Investigators, The MuTHER Consortium, et al. (2015) · Nature · doi:10.1038/nature14177 · Cited by 4,534
Hubert, H. B., Feinleib, M., McNamara, P. M., & Castelli, W. P. (1983) · Circulation · doi:10.1161/01.cir.67.5.968 · Cited by 4,241
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
The Look AHEAD Research Group (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1212914 · Cited by 2,908
Health and economic burden of the projected obesity trends in the USA and the UK
Wang, Y. C., McPherson, K., Marsh, T., Gortmaker, S. L., & Brown, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60814-3 · Cited by 2,775
DeFronzo, R. A., Ferrannini, E., Groop, L., Henry, R. R., Herman, W. H., Holst, J. J., Hu, F. B., Kahn, C. R., Raz, I., Shulman, G. I., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.19 · Cited by 2,611
Body-mass index and mortality among 1.46 million white adults
Berrington de Gonzalez, A., Hartge, P., Cerhan, J. R., Flint, A. J., Hannan, L., MacInnis, R. J., Moore, S. C., Tobias, G. S., Anton-Culver, H., Freeman, L. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000367 · Cited by 2,317
Research works printed but not linked: 6
- JASSO, 2002, Examination committee of criteria for ‘obesity disease’ in Japan; Japan Society for the Study of Obesity. New criteria for ‘obesity disease’ in Japan, Circ J, 66, 987
- Nagoya Declaration 2015. The 8th Asia‐Oceania Conference on Obesity (AOCO 2015).http://www.jasso.or.jp/data/data/pdf/nagoya2015.pdf
- Flemyng M, 1760, A Discourse on the Nature, Causes and Cure of Corpulency
- Wadd W, 1816, Cursory Remarks on Corpulence; or Obesity Considered as a Disease: With a Critical Examination of Ancient and Modern Opinion, Relative to its Causes and Cure
- Putnam JJ, 1999, Food consumption, prices, and expenditures, 1970–1997. USDA Food and Agriculture Economic Division, Economic Research Service Bull, 965, 1
- 10.1038/nature14177 · DOI · Paper page
Cited by
Sorted by citations
Obesity: global epidemiology and pathogenesis
Blüher, M. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0176-8 · Cited by 5,126
The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report
Swinburn, B. A., Kraak, V. I., Allender, S., Atkins, V. J., Baker, P. I., Bogard, J. R., Brinsden, H., Calvillo, A., De Schutter, O., Devarajan, R., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32822-8 · Cited by 3,081
Definition and diagnostic criteria of clinical obesity
Rubino, F., Cummings, D. E., Eckel, R. H., Cohen, R. V., Wilding, J. P. H., Brown, W. A., Stanford, F. C., Batterham, R. L., Farooqi, I. S., Farpour-Lambert, N. J., et al. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00316-4 · Cited by 1,811
Self-citationObesity: Epidemiology, Pathophysiology, and Therapeutics
Lin, X., & Li, H. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.706978 · Cited by 1,530
Joint international consensus statement for ending stigma of obesity
Rubino, F., Puhl, R. M., Cummings, D. E., Eckel, R. H., Ryan, D. H., Mechanick, J. I., Nadglowski, J., Ramos Salas, X., Schauer, P. R., Twenefour, D., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0803-x · Cited by 1,152
Blüher, M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa004 · Cited by 1,090
Anti-obesity drug discovery: advances and challenges
Müller, T. D., Blüher, M., Tschöp, M. H., & DiMarchi, R. D. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00337-8 · Cited by 1,021
Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body
Cristofori, F., Dargenio, V. N., Dargenio, C., Miniello, V. L., Barone, M., & Francavilla, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.578386 · Cited by 991
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial
Garvey, W. T., Batterham, R. L., Bhatta, M., Buscemi, S., Christensen, L. N., Frias, J. P., Jódar, E., Kandler, K., Rigas, G., Wadden, T. A., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-02026-4 · Cited by 868
Economic impacts of overweight and obesity: current and future estimates for 161 countries
Okunogbe, A., Nugent, R. A., Spencer, G., Powis, J., Ralston, J., & Wilding, J. P. H. (2022) · BMJ Global Health · doi:10.1136/bmjgh-2022-009773 · Cited by 845
Self-citationOnce-weekly semaglutide in adolescents with obesity
Weghuber, D., Barrett, T., Barrientos-Pérez, M., Gies, I., Hesse, D., Jeppesen, O. K., Kelly, A. S., Mastrandrea, L. D., Sørrig, R., & Arslanian, S. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2208601 · Cited by 730
A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity
Kelly, A. S., Auerbach, P., Barrientos-Perez, M., Gies, I., Hale, P. M., Marcus, C., Mastrandrea, L. D., Prabhu, N., & Arslanian, S. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1916038 · Cited by 723
Karlsen, T. H., Sheron, N., Zelber-Sagi, S., Carrieri, P., Dusheiko, G., Bugianesi, E., Pryke, R., Hutchinson, S. J., Sangro, B., Martin, N. K., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)01701-3 · Cited by 652
Mechanick, J. I., Apovian, C., Brethauer, S., Garvey, W. T., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah-Pollack, R., Seger, J., et al. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.10.025 · Cited by 608
Mechanick, J. I., Apovian, C., Brethauer, S., Garvey, W. T., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah-Pollack, R., Seger, J., et al. (2019) · Endocrine Practice · doi:10.4158/gl-2019-0406 · Cited by 510
A new framework for the diagnosis, staging and management of obesity in adults
Busetto, L., Dicker, D., Frühbeck, G., Halford, J. C. G., Sbraccia, P., Yumuk, V., & Goossens, G. H. (2024) · Nature Medicine · doi:10.1038/s41591-024-03095-3 · Cited by 501
Obesity as a Disease: The Obesity Society 2018 Position Statement
Jastreboff, A. M., Kotz, C. M., Kahan, S., Kelly, A. S., & Heymsfield, S. B. (2019) · Obesity · doi:10.1002/oby.22378 · Cited by 457
Knop, F. K., Aroda, V. R., do Vale, R. D., Holst-Hansen, T., Laursen, P. N., Rosenstock, J., Rubino, D. M., & Garvey, W. T. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01185-6 · Cited by 431
Adipokines and Obesity. Potential Link to Metabolic Disorders and Chronic Complications
Zorena, K., Jachimowicz-Duda, O., Ślęzak, D., Robakowska, M., & Mrugacz, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103570 · Cited by 411
The Role of Probiotics and Prebiotics in the Prevention and Treatment of Obesity
Cerdó, T., García-Santos, J. A., García-Bermúdez, M., & Campoy, C. (2019) · Nutrients · doi:10.3390/nu11030635 · Cited by 439
Chen, K., Shen, Z., Gu, W., Lyu, Z., Qi, X., Mu, Y., Ning, Y., & for the Meinian Investigator Group (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15238 · Cited by 407
Upadhyay, J., Farr, O. M., Perakakis, N., Ghaly, W., & Mantzoros, C. S. (2017) · Medical Clinics of North America · doi:10.1016/j.mcna.2017.08.004 · Cited by 425
Mechanick, J. I., Apovian, C. M., Brethauer, S. A., Garvey, W. T., Joffe, A. M., Kim, J. J., Kushner, R. F., Lindquist, R., Pessah‐Pollack, R., Seger, J., et al. (2020) · Obesity · doi:10.1002/oby.22719 · Cited by 425
Economic Impacts of Overweight and Obesity: Current and Future Estimates for Eight Countries
Okunogbe, A., Nugent, R. A., Spencer, G., Ralston, J., & Wilding, J. P. H. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2021-006351 · Cited by 440
Self-citationObesity cardiomyopathy: evidence, mechanisms, and therapeutic implications
Ren, J. T., Wu, N. N., Wang, S., Sowers, J. R., & Zhang, Y. (2021) · Physiological Reviews · doi:10.1152/physrev.00030.2020 · Cited by 388
Why primary obesity is a disease?
LORENZO, A. D., Gratteri, S., Gualtieri, P., Cammarano, A., Bertucci, P., & Renzo, L. D. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1919-y · Cited by 398
Lopez-Jimenez, F., Almahmeed, W., Bays, H., Cuevas, A., Di Angelantonio, E., le Roux, C. W., Sattar, N., Sun, M. C., Wittert, G., Pinto, F. J., et al. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwac187 · Cited by 362
Self-citationNg, M., Dai, X., Cogen, R. M., Abdelmasseh, M., Abdollahi, A., Abdullahi, A., Aboagye, R. G., Abukhadijah, H. J., Adeyeoluwa, T. E., Afolabi, A. A., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01548-4 · Cited by 407
Progress and challenges in anti-obesity pharmacotherapy
Bessesen, D. H., & Van Gaal, L. F. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30236-x · Cited by 347
Associations between vascular risk factors and brain MRI indices in UK Biobank
Cox, S. R., Lyall, D. M., Ritchie, S. J., Bastin, M. E., Harris, M. A., Buchanan, C. R., Fawns‐Ritchie, C., Barbu, M. C., de Nooij, L., Reus, L. M., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz100 · Cited by 332
Obesity Stigma: Causes, Consequences, and Potential Solutions
Westbury, S., Oyebode, O., van Rens, T., & Barber, T. M. (2023) · Current Obesity Reports · doi:10.1007/s13679-023-00495-3 · Cited by 317
Perceptions of Barriers to Effective Obesity Care: Results from the National ACTION Study
Kaplan, L. M., Golden, A., Jinnett, K., Kolotkin, R. L., Kyle, T. K., Look, M., Nadglowski, J., O'Neil, P. M., Parry, T., Tomaszewski, K. J., et al. (2018) · Obesity · doi:10.1002/oby.22054 · Cited by 312
Semaglutide for the treatment of overweight and obesity: A review
Bergmann, N. C., Davies, M. J., Lingvay, I., & Knop, F. K. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14863 · Cited by 265
Vallianou, N. G., Stratigou, T., Christodoulatos, G. S., Tsigalou, C., & Dalamaga, Μ. (2020) · Current Obesity Reports · doi:10.1007/s13679-020-00379-w · Cited by 263
Ells, L. J., Rees, K., Brown, T. J., Mead, E., Al-Khudairy, L., Azevedo, L. B., McGeechan, G., Baur, L. A., Loveman, E., Clements, H., et al. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0230-y · Cited by 256
Pillon, N. J., Loos, R. J. F., Marshall, S. M., & Zierath, J. R. (2021) · Cell · doi:10.1016/j.cell.2021.02.012 · Cited by 247
Salminen, P. T. P., Kow, L., Aminian, A., Kaplan, L. M., Nimeri, A. A., Prager, G., Behrens, E. J., White, K. P., Shikora, S. A., Panel, I. E., et al. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06913-8 · Cited by 241
le Roux, C. W., Steen, O., Lucas, K. J., Startseva, E., Unseld, A., & Hennige, A. M. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00356-x · Cited by 237
DeLoid, G. M., Sohal, I. S., Rubio, L., Molina, R. M., Pyrgiotakis, G., Stevanović, A., Zhang, R., McClements, D. J., Geitner, N. K., Bousfield, D. W., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b03074 · Cited by 214
Gaps to bridge: Misalignment between perception, reality and actions in obesity
Caterson, I. D., Alfadda, A. A., Auerbach, P., Coutinho, W., Cuevas, A., Dicker, D., Hughes, C., Iwabu, M., Kang, J., Nawar, R., et al. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13752 · Cited by 210
Bray, G. A. (2023) · Nutrients · doi:10.3390/nu15102254 · Cited by 210
Self-citationThe Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma
Zaman, S. J., Wasfy, J. H., Kapil, V., Ziaeian, B., Parsonage, W. A., Sriswasdi, S., Chico, T., Capodanno, D., Colleran, R., Sutton, N. R., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)00055-8 · Cited by 236
A review of current guidelines for the treatment of obesity
(2022) · The American Journal of Managed Care · doi:10.37765/ajmc.2022.89292 · Cited by 207
Obesity: A preventable, treatable, but relapsing disease
LORENZO, A. D., Romano, L., Renzo, L. D., Lorenzo, N. D., Cenname, G., & Gualtieri, P. (2019) · Nutrition · doi:10.1016/j.nut.2019.110615 · Cited by 221
Aging, obesity, sarcopenia and the effect of diet and exercise intervention
Colleluori, G., & Villareal, D. T. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111561 · Cited by 217
Garvey, W. T., Birkenfeld, A. L., Dicker, D., Mingrone, G., Pedersen, S. D., Satylganova, A., Skovgaard, D., Sugimoto, D., Jensen, C., & Mosenzon, O. (2020) · Diabetes Care · doi:10.2337/dc19-1745 · Cited by 186
AgRP/NPY and POMC neurons in the arcuate nucleus and their potential role in treatment of obesity
Vohra, M. S., Benchoula, K., Serpell, C. J., & Wong, E. H. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174611 · Cited by 199
Obesity and Its Related Diseases: A New Escalating Alarming in Global Health
Mohajan, D., & Mohajan, H. K. (2023) · Journal of Innovations in Medical Research · doi:10.56397/jimr/2023.03.04 · Cited by 207
Obesity Paradox: Fact or Fiction?
Simati, S., Kokkinos, A. D., Dalamaga, Μ., & Argyrakopoulou, G. (2023) · Current Obesity Reports · doi:10.1007/s13679-023-00497-1 · Cited by 186
Obesity in South and Southeast Asia—A new consensus on care and management
Tham, K. W., Abdul Ghani, R., Cua, S. C., Deerochanawong, C., Fojas, M., Hocking, S., Lee, J., Nam, T. Q., Pathan, F., Saboo, B., et al. (2023) · Obesity Reviews · doi:10.1111/obr.13520 · Cited by 187
Sartoretto, A., Sui, Z., Hill, C., Dunlap, M. K., Rivera, A. R., Khashab, M. A., Kalloo, A. N., Fayad, L., Cheskin, L. J., Marinos, G., et al. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3135-x · Cited by 161
New insights into the treatment of obesity
Blüher, M., Aras, M., Aronne, L. J., Batterham, R. L., Giorgino, F., Ji, L., Pietiläinen, K. H., Schnell, O., Tonchevska, E., & Wilding, J. P. H. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15077 · Cited by 158
Self-citationFood insecurity as a risk factor for obesity: A review
Carvajal‐Aldaz, D., Cucalón, G., & Ordóñez, C. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1012734 · Cited by 149
García‐Estévez, L., Cortés, J., Pérez, S., Calvo, I., Gallegos, I., & Moreno‐Bueno, G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.705911 · Cited by 154
Rosa, G. P., Tavares, W. R., Sousa, P. M. C., Kane-Pagès, A., Seca, A. M. L., & Pinto, D. C. G. A. (2019) · Marine Drugs · doi:10.3390/md18010008 · Cited by 151
Economic costs of obesity: a systematic review
Nagi, M. A., Ahmed, H., Rezq, M. A. A., Sangroongruangsri, S., Chaikledkaew, U., Almalki, Z. S., & Thavorncharoensap, M. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01398-y · Cited by 156
Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes
Tan, Q., Akindehin, S. E., Orsso, C. E., Waldner, R. C., DiMarchi, R. D., Müller, T. D., & Haqq, A. M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.838410 · Cited by 146
Kloock, S., Ziegler, C. G., & Dischinger, U. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108549 · Cited by 173
DeLoid, G. M., Cao, X., Molina, R. M., Silva, D. I. D. S. B. D. C. E., Bhattacharya, K., Ng, K. W., Loo, S. C. J., Brain, J. D., & Demokritou, P. (2019) · Environmental Science Nano · doi:10.1039/c9en00184k · Cited by 145
Liraglutide for Children 6 to <12 Years of Age with Obesity — A Randomized Trial
Fox, C. K., Barrientos-Pérez, M., Bomberg, E. M., Dcruz, J., Gies, I., Harder-Lauridsen, N. M., Jalaludin, M. Y., Sahu, K., Weimers, P., Zueger, T., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2407379 · Cited by 142
Nadolsky, K., Garvey, W. T., Agarwal, M., Bonnecaze, A., Burguera, B., Chaplin, M. D., Griebeler, M. L., Harris, S. R., Schellinger, J. N., Simonetti, J., et al. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.07.017 · Cited by 141
Nutritional considerations with antiobesity medications
Almandoz, J. P., Wadden, T. A., Tewksbury, C., Apovian, C. M., Fitch, A., Ard, J. D., Li, Z., Richards, J., Butsch, W. S., Jouravskaya, I., et al. (2024) · Obesity · doi:10.1002/oby.24067 · Cited by 134
“Obesity is a chronic, relapsing, and progressive disease associated with over 200 complications and an increased risk of premature mortality [1 – 4].”
BackgroundSeidu, S., Gillies, C., Zaccardi, F., Kunutsor, S. K., Hartmann‐Boyce, J., Yates, T. E., Singh, A. K., Davies, M. J., & Khunti, K. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.176 · Cited by 134
Fitch, A., & Bays, H. E. (2022) · Obesity Pillars · doi:10.1016/j.obpill.2021.100004 · Cited by 145
Bray, G. A., & Ryan, D. H. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14200 · Cited by 148
Self-citationA comprehensive diagnostic approach to detect underlying causes of obesity in adults
van der Valk, E. S., van den Akker, E. L. T., Savas, M., Kleinendorst, L., Visser, J. A., van Haelst, M. M., Sharma, A. M., & van Rossum, E. F. C. (2019) · Obesity Reviews · doi:10.1111/obr.12836 · Cited by 138
Mu, Y., Bao, X., Eliaschewitz, F. G., Hansen, M., Kim, B. T., Koroleva, A., Ronald, C. W., Yang, T., Zu, N., & Liu, M. R. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00388-1 · Cited by 141
Wadden, T. A., Chao, A. M., Moore, M., Tronieri, J. S., Gilden, A., Amaro, A., Leonard, S., & Jakicic, J. M. (2023) · Current Obesity Reports · doi:10.1007/s13679-023-00534-z · Cited by 129
INTERDISCIPLINARY CLINICAL PRACTICE GUIDELINES "MANAGEMENT OF OBESITY AND ITS COMORBIDITIES"
Dedov, I. I., Shestakova, M. V., Mel'nichenko, G. A., Mazurina, N. V., Andreeva, E. N., Bondarenko, I. Z., Руслановна, Г. З., Dzgoeva, F. K., Елисеев, М. С., Ershova, E. V., et al. (2021) · Obesity and metabolism · doi:10.14341/omet12714 · Cited by 163
Lancet Diabetes & Endocrinology Commission on the Definition and Diagnosis of Clinical Obesity
Rubino, F., Batterham, R. L., Koch, M., Mingrone, G., le Roux, C. W., Farooqi, I. S., Farpour-Lambert, N., Gregg, E. W., & Cummings, D. E. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00058-x · Cited by 126
Kosiborod, M. N., Bhatta, M., Davies, M., Deanfield, J. E., Garvey, W. T., Khalid, U., Kushner, R., Rubino, D. M., Zeuthen, N., & Verma, S. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14890 · Cited by 127
Mastrocola, M. R., Roque, S. S., Benning, L. V., & Stanford, F. C. (2020) · International Journal of Obesity · doi:10.1038/s41366-019-0453-6 · Cited by 127
Mikulska, A. A., Karaźniewicz‐Łada, M., Filipowicz, D., Ruchała, M., & Główka, F. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126580 · Cited by 146
Dietary Regulation of Immunity
Lee, A. H., & Dixit, V. D. (2020) · Immunity · doi:10.1016/j.immuni.2020.08.013 · Cited by 127
Mannan-oligosaccharide modulates the obesity and gut microbiota in high-fat diet-fed mice
Wang, H., Zhang, X., Wang, S., Li, H., Lu, Z., Shi, J., & Xu, Z. (2018) · Food & Function · doi:10.1039/c8fo00209f · Cited by 125
Horn, D. B., Almandoz, J. P., & Look, M. (2022) · Postgraduate Medicine · doi:10.1080/00325481.2022.2051366 · Cited by 114
Probiotics supplementation and insulin resistance: A systematic review
Salles, B. I. M., Cioffi, D., & Ferreira, S. R. G. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00603-6 · Cited by 114
Pan, W., Zhao, J., Wu, J., Xu, D., Meng, X., Jiang, P., Shi, H., Ge, X., Yang, X., Hu, M., et al. (2023) · Microbiome · doi:10.1186/s40168-023-01471-8 · Cited by 113
Gut hormone polyagonists for the treatment of type 2 diabetes
Brandt, S. J., Götz, A., Tschöp, M. H., & Müller, T. D. (2018) · Peptides · doi:10.1016/j.peptides.2017.12.021 · Cited by 108
Machado, A. M., Guimarães, N. S., Bocardi, V. B., da Silva, T. P. R., Carmo, A. S. D., Menezes, M. C. D., & Duarte, C. K. (2022) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2022.03.020 · Cited by 109
Obesity and sleep disorders: A bidirectional relationship
Figorilli, M., Velluzzi, F., & Redolfi, S. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104014 · Cited by 130
Müller, M. J., & Geisler, C. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.155 · Cited by 109
Lewis, K. H., Fischer, H., Ard, J., Barton, L., Bessesen, D. H., Daley, M. F., Desai, J., Fitzpatrick, S. L., Horberg, M., Koebnick, C., et al. (2019) · Obesity · doi:10.1002/oby.22430 · Cited by 110
A Role for GLP-1 in Treating Hyperphagia and Obesity
Grill, H. J. (2020) · Endocrinology · doi:10.1210/endocr/bqaa093 · Cited by 101
Alba, M., Yee, J., Frustaci, M. E., Samtani, M. N., & Fleck, P. (2021) · Clinical Obesity · doi:10.1111/cob.12432 · Cited by 100
Food for Thought: Reward Mechanisms and Hedonic Overeating in Obesity
Lee, P. C., & Dixon, J. B. (2017) · Current Obesity Reports · doi:10.1007/s13679-017-0280-9 · Cited by 97
Autoantibody Production in Obesity: Is There Evidence for a Link Between Obesity and Autoimmunity?
Tsigalou, C., Vallianou, N. G., & Dalamaga, Μ. (2020) · Current Obesity Reports · doi:10.1007/s13679-020-00397-8 · Cited by 101
Preguiça, I., Alves, A., Nunes, S., Fernandes, R., Gomes, P., Viana, S., & Reis, F. (2020) · Obesity Reviews · doi:10.1111/obr.13081 · Cited by 123
Anti-Obesity Effects of Dietary Calcium: The Evidence and Possible Mechanisms
Zhang, F., Ye, J., Zhu, X., Wang, L., Gao, P., Shu, G., Jiang, Q., & Wang, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20123072 · Cited by 95
Reappraising the role of the vagus nerve in GLP-1-mediated regulation of eating
Brierley, D. I., & de Lartigue, G. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15603 · Cited by 92
Periodontitis and metabolic diseases (diabetes and obesity): Tackling multimorbidity
Marruganti, C., Suvan, J. E., & D’Aiuto, F. (2023) · Periodontology 2000 · doi:10.1111/prd.12536 · Cited by 102
Obesity: pathophysiology and therapeutic interventions
Kong, Y., Yang, H., Nie, R., Zhang, X., Zuo, F., Zhang, H., & Nian, X. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00264-9 · Cited by 89
Effects of ingested nanocellulose on intestinal microbiota and homeostasis in Wistar Han rats
Khare, S., DeLoid, G. M., Molina, R. M., Gokulan, K., Couvillion, S., Bloodsworth, K., Eder, E., Wong, A. R., Hoyt, D. W., Bramer, L., et al. (2020) · NanoImpact · doi:10.1016/j.impact.2020.100216 · Cited by 88
The Role of Exercise, Diet, and Cytokines in Preventing Obesity and Improving Adipose Tissue
ATAKAN, M. M., Koşar, Ş. N., Güzel, Y., Tin, H. T., & Yan, X. (2021) · Nutrients · doi:10.3390/nu13051459 · Cited by 96
Pontes, K. S. D. S., Guedes, M. R., Cunha, M. R. D., Mattos, S. D. S., Barreto Silva, M. I., Neves, M. F., Marques, B. C. A. A., & Klein, M. R. S. T. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.06.023 · Cited by 86
Perceptions of barriers to effective obesity management in Canada: Results from the ACTION study
Sharma, A. M., Bélanger, A., Carson, V., Krah, J., Langlois, M., Lawlor, D., Lepage, S., Liu, A., Macklin, D. A., MacKay, N., et al. (2019) · Clinical Obesity · doi:10.1111/cob.12329 · Cited by 86
The economic burden of obesity in Italy: a cost-of-illness study
d’Errico, M., Pavlova, M., & Spandonaro, F. (2021) · The European Journal of Health Economics · doi:10.1007/s10198-021-01358-1 · Cited by 87
Multifactorial Basis and Therapeutic Strategies in Metabolism-Related Diseases
Guerra, J. V. D. S., Dias, M. M. G., Brilhante, A. J. V. C., Terra, M. F., García‐Arévalo, M., & Figueira, A. C. M. (2021) · Nutrients · doi:10.3390/nu13082830 · Cited by 92
Yang, M., Bose, S., Lim, S.-K., Seo, J., Shin, J., Lee, D., Chung, W., Song, E., Nam, Y., & Kim, H. (2020) · Microorganisms · doi:10.3390/microorganisms8091413 · Cited by 89
Addressing weight bias and discrimination: moving beyond raising awareness to creating change
Salas, X. R., Alberga, A. S., Cameron, E., Estey, L., Forhan, M. A., Kirk, S., Russell‐Mayhew, S., & Sharma, A. M. (2017) · Obesity Reviews · doi:10.1111/obr.12592 · Cited by 83
Metadata
- Authors
- Bray, G. A., Kim, K. K., Wilding, J. P. H., & on behalf of the World Obesity Federation
- Affiliations
- Pennington Biomedical Research Center (US)
- National University of Korea Seoul Korea
- University of Liverpool (GB)
- Corresponding author
- Bray, G.A.
- Venue
- Obesity Reviews
- Publisher
- Wiley
- Published
- 2017-05-10
- Volume
- 18
- Issue
- 7
- Pages
- 715-723
- ISSN
- 1467-7881 (ISSN-L)
- 1467-789X
- OpenAlex
- W2612234120
- Semantic Scholar
- ce5fd22f0c153b958215267e8671a3398a9eccaa
- Cited by
- 1,612
- References
- 91
- Citations by year
- 2026: 210 · 2025: 242 · 2024: 243 · 2023: 217 · 2022: 191 · 2021: 202 · 2020: 135 · 2019: 107 · 2018: 48 · 2017: 15
- FWCI
- 78.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Obesity Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity and Health Practices
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- obesity, chronic relapsing disease, disease models, energy balance, energy-dense foods, sugar-sweetened beverages, physical inactivity, genetic susceptibility, adipose tissue, ectopic fat, liver fat, metabolic inflammation, host-environment interactions, obesity reversal
- MeSH terms
- Chronic Disease, Diet, Dietary Carbohydrates, Dietary Fats, Environment, Food, Humans, Obesity, Recurrence, Weight Gain, Exercise
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
